BRD2492, also known by its CAS number 1821669-43-5, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential as a therapeutic agent. It is characterized by its specific molecular structure, which includes various functional groups that contribute to its biological activity. BRD2492 has been studied for its role as a selective inhibitor of certain enzymes or pathways, making it a candidate for drug development in treating various diseases. The compound's solubility, stability, and reactivity are important factors that influence its efficacy and safety profile. Additionally, BRD2492's pharmacokinetic properties, such as absorption, distribution, metabolism, and excretion (ADME), are critical for understanding its behavior in biological systems. Research continues to explore its mechanism of action and potential applications in clinical settings, highlighting the importance of ongoing studies to fully elucidate its characteristics and therapeutic potential.

BRD2492 is a novel potent HDAC1/2 inhibitor.

BRD2492 

(BRD 2492)

1821669-43-5: BRD2492, also known by its CAS number 1821669-43-5, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential as a therapeutic agent. It is characterized by its specific molecular structure, which includes various functional groups that contribute to its biological activity. BRD2492 has been studied for its role as a selective inhibitor of certain enzymes or pathways, making it a candidate for drug development in treating various diseases. The compound's solubility, stability, and reactivity are important factors that influence its efficacy and safety profile. Additionally, BRD2492's pharmacokinetic properties, such as absorption, distribution, metabolism, and excretion (ADME), are critical for understanding its behavior in biological systems. Research continues to explore its mechanism of action and potential applications in clinical settings, highlighting the importance of ongoing studies to fully elucidate its characteristics and therapeutic potential.

BRD2492

<p>BRD2492 is an HDAC1 and HDAC2 inhibitor with antiproliferative activity, inhibits HDAC1/2 and induces apoptosis.</p>

CAS 1821669-43-5

BRD2492 (BRD 2492)

BRD2492

Ref: 54-BUP07824

BRD2492

Ref: TM-T26897